Andrzej Balicki, Ph.D., heads DLA Piper’s Life Sciences Practice in Warsaw. He has almost 20 years of experience in advising on both EU and national regulations of pharmaceuticals, medicinal devices, diet supplements and healthcare services. Andrzej has worked on high profile projects involving manufacturing, distribution, clinical trials, promotion and advertising, pricing and reimbursement, as well as AI Health-Tech solutions. He has participated in the regulatory work of public bodies, including working groups at the Office of Competition and Consumer Protection, the Ministry of Health and the Parliamentary Subcommittee on Public Health. He was awarded a Ph.D. at the University of Warsaw for a dissertation on the EU internal market of pharmaceuticals, after receiving a research grant to spend one year at the University of Oxford. He co-authored the first commentary on the Polish Food Law as well as the first Polish commentary on Regulation 1924/2006 on nutrition and health claims (Wolters Kluwer).
Andrzej is recognized as a Leading Individual in Healthcare & Life Sciences in Poland (Legal 500 EMEA).